Why Is ROP (Retinopathy of Prematurity) Screening Done for Premature Babies and When?

The eye doctor came to the incubator on a Tuesday morning, unannounced as far as the parents were concerned, carrying a small metal instrument and a headlamp. Their daughter had been born at 27 weeks and was, by every account, doing well: gaining weight, tolerating milk, off the ventilator. So why, the mother asked, did a baby who had never opened her eyes for more than a few seconds need her retinas examined?

That question sits at the heart of retinopathy of prematurity screening. Retinopathy of prematurity, usually shortened to ROP, is a disorder in which the blood vessels of the retina, the light-sensing layer at the back of the eye, grow abnormally after a very early birth. In its early stages it is silent. A baby cannot report blurry vision, and there is nothing a parent could spot from the outside.

What follows is a plain account of why the exams happen, who is on the list, when the first one is scheduled, what a baby actually experiences, and what the results mean. The decisions along the way belong to the neonatal and eye teams caring for your child; the goal here is to make their explanations easier to follow.

What is retinopathy of prematurity, in plain language?

Picture the retina as a thin sheet of wallpaper lining the back of the eye. During pregnancy, blood vessels grow across that sheet from the center outward, starting near the optic nerve and reaching the far edges only in the final weeks before a full-term birth. According to MedlinePlus, this vessel growth is not complete until roughly 40 weeks of gestation.

A baby born at 26 or 28 weeks therefore arrives with a retina that is only partly supplied with blood. Growth is supposed to continue after birth, but the world outside the womb is a very different chemical environment. Oxygen levels swing, growth factors that circulated from the placenta disappear, and the immature vessels can stall. Later, when the retina signals for more blood supply, vessels may grow back too fast and in the wrong direction, pushing into the jelly-like center of the eye rather than lying flat.

Those abnormal vessels are fragile. They can bleed, and they can form scar tissue that contracts and pulls on the retina. In the most severe cases the retina detaches, which is why ROP remains one of the leading causes of childhood blindness worldwide, a point the NIH National Eye Institute makes in its overview of the condition.

Two facts matter more than the rest. First, most babies who develop ROP have a mild form that settles on its own without treatment, as the National Eye Institute notes. Second, the minority who progress to severe disease do so within a fairly predictable window of weeks, and that window is exactly what the screening schedule is built around.

Why is retinopathy of prematurity screening done at all?

Screening exists because ROP breaks one of the usual rules of medicine: it produces no symptoms while it is still treatable. A baby with early ROP looks, feeds and behaves no differently from a baby with a healthy retina. By the time a problem becomes visible to a parent or a pediatrician, for example a white pupil or an eye that wanders, the damage may already be permanent.

The disease also has a reasonably well-defined danger period. The American Academy of Pediatrics policy statement on ROP screening, indexed on PubMed, describes how the timing of severe disease is governed more by the baby’s postmenstrual age (weeks since the mother’s last menstrual period, combining gestation and time since birth) than by how many weeks the baby has been alive. Severe ROP rarely appears before about 31 weeks postmenstrual age, and the risk tails off as the retina finishes developing. A screening program can therefore concentrate exams in the weeks when they can change the outcome.

There is a third reason. Effective treatments exist, and they work best when applied at a specific stage. The Early Treatment for Retinopathy of Prematurity findings that underpin the current American Academy of Pediatrics guidance showed that treating certain high-risk patterns, now called type 1 ROP, before the retina detaches gives better structural results than waiting. Treatment that late is far harder and far less likely to preserve sight, as the National Eye Institute explains.

Put those three things together, silent disease, predictable timing and time-sensitive treatment, and the logic of retinopathy of prematurity screening is straightforward. It is not a routine formality added to the discharge checklist. It is the only reliable way to find the small number of babies who need an intervention before the chance to help them has passed.

Who qualifies for the ROP exam? The ROP screening criteria explained

Not every baby in a neonatal unit is screened. The criteria are designed to capture nearly all infants who could develop treatable disease while sparing more mature babies an exam they are very unlikely to need.

In the United States, the American Academy of Pediatrics policy statement recommends screening for infants with a birth weight of 1,500 grams (roughly 3 pounds 5 ounces) or less, or a gestational age of 30 weeks or less. It adds a second category: babies who weigh between 1,500 and 2,000 grams or were born after 30 weeks but whose clinical course has been unstable, such as those who needed prolonged breathing support or had a serious infection, when the treating neonatologist judges them to be at higher risk. That judgment call is deliberately left to the bedside team.

Cleveland Clinic and MedlinePlus describe the same broad pattern: the earlier and smaller the baby, the higher the chance of ROP and the more likely screening becomes. A baby born at 24 weeks is in a very different risk bracket from one born at 30 weeks and 6 days, even though both meet the criteria.

Other countries set their thresholds slightly differently, sometimes by a week of gestation or a few grams of weight, reflecting local birth-weight distributions and neonatal practice. What they share is the same underlying idea of selecting by gestation, birth weight and clinical instability.

Beyond the formal criteria, several factors nudge risk upward and are often mentioned in conversations with parents. MedlinePlus lists high oxygen exposure in the early days, anemia, blood transfusions, breathing difficulties and slow weight gain among them. None of these alone triggers screening in a larger baby, but they help explain why two infants with identical birth details can have different exam schedules.

Who is usually asked to wait, and who does not need screening?

Parents in a neonatal unit compare notes, and it can be unsettling to learn that the baby in the next cot had an eye exam while yours has not. There are three common explanations, and none of them means your child has been overlooked.

The first is that your baby does not meet the criteria. An infant born at 33 weeks weighing 2,100 grams, who breathed on their own from the start, falls outside the American Academy of Pediatrics thresholds. The retina of such a baby is already largely vascularized, and the risk of treatable ROP is very low. Skipping the exam spares the baby a stressful procedure with essentially no expected benefit.

The second is timing. A baby who qualifies but was born at 25 weeks will not be examined at two weeks of age, because severe disease does not develop that early, and examining an immature retina too soon adds discomfort without adding information. The first exam is scheduled by postmenstrual age, so a very early baby waits longer after birth than a baby born at 30 weeks. The next section explains how that date is set.

The third is clinical stability. If a baby is critically unwell, on high-frequency ventilation or recovering from surgery, the eye team may agree with the neonatologists to delay an exam by a few days. The American Academy of Pediatrics guidance acknowledges that examination timing can be adjusted for a baby’s overall condition, provided the delay is documented and kept short.

Finally, screening ends. Once the eye doctor confirms that the retina is fully developed, or that mild ROP has regressed, the baby comes off the list even if they are still in the unit for other reasons. Being discharged from ROP screening is good news, not a sign of neglect.

When is ROP screening done? Timing of the first exam

The first exam is scheduled using two clocks at once. One is postmenstrual age, counted from the mother’s last period. The other is chronologic age, the number of weeks since birth. The American Academy of Pediatrics policy statement recommends the first exam at 31 weeks postmenstrual age or four weeks after birth, whichever comes later.

That rule produces different calendars for different babies. A baby born at 24 weeks reaches 31 weeks postmenstrual age at seven weeks of life, so the first exam happens around then. A baby born at 29 weeks would reach 31 weeks postmenstrual age at only two weeks old, but the four-week minimum pushes the exam to four weeks of life, when the baby is 33 weeks postmenstrual age. The table below shows how the two clocks combine.

Gestational age at birth	Age at first exam (chronologic)	Postmenstrual age at first exam
24 weeks	7 weeks	31 weeks
25 weeks	6 weeks	31 weeks
26 weeks	5 weeks	31 weeks
27 weeks	4 weeks	31 weeks
28 weeks	4 weeks	32 weeks
29 weeks	4 weeks	33 weeks
30 weeks	4 weeks	34 weeks

The schedule is derived from the American Academy of Pediatrics guidance and is a typical framework, not a promise; individual units may shift a date by a few days for clinical reasons. The logic behind the four-week floor is that even a relatively mature preterm baby needs time after birth before ROP could plausibly appear, while the 31-week floor reflects how rarely severe disease is seen before that point.

Parents are usually told the expected week of the first exam early in the admission. If you have not been told, asking the neonatal team to write it in your baby’s notes or on the cot card is entirely reasonable.

What actually happens during a retinopathy of prematurity exam

The exam is quick but not trivial, and it helps to know the steps in advance. About 30 to 60 minutes beforehand, a nurse instills eye drops that widen the pupil, sometimes in more than one round. The specific medicines and how they are given are chosen by the unit’s protocol and the treating team; the point is simply that the pupil needs to be open wide enough for the doctor to see the retina all the way to its edges.

The ophthalmologist, a doctor who specializes in the eye, then places a small wire device called an eyelid speculum to hold the eyelids gently apart. Numbing drops are typically used first. Wearing an indirect ophthalmoscope, a headlamp paired with a hand-held lens, the doctor looks through the pupil and may use a blunt instrument called a scleral depressor to tilt the eye slightly and bring the far edges of the retina into view. Cleveland Clinic describes this as the standard method for examining the peripheral retina in infants.

Each eye takes a few minutes. Babies often cry, and heart rate or oxygen readings can dip briefly; a nurse stays alongside to monitor. Comfort measures are part of good practice rather than an afterthought. Many units swaddle the baby, offer a pacifier, allow a parent to place a steadying hand, and use a small amount of sugar solution on the tongue, which has a calming effect during brief procedures. Feeding may be timed so the stomach is not full during the exam, following the unit’s routine.

Some centers photograph the retina with a wide-field digital camera instead of, or in addition to, the direct exam. The images are read by an ophthalmologist, sometimes at a distance. The American Academy of Pediatrics statement recognizes this approach as an option within a structured program, with the same follow-up rules applied to what the images show.

How are results described? ROP stages and zones made simple

After the exam, the ophthalmologist records findings in a standardized language that can sound like code. It has three parts: where the disease is (zone), how advanced it is (stage), and whether the vessels look dilated and twisted (plus disease).

Zones describe location using the optic nerve as the center of a target. Zone I is the innermost circle around the nerve and the central retina; disease here is most concerning because the retina has the furthest still to grow. Zone II is the middle ring. Zone III is the outer crescent on the far side of the eye, where vessels finish last and disease is usually mildest.

Stages describe severity, from 1 to 5, as MedlinePlus and the National Eye Institute both outline. Stage 1 is a faint line between vascularized and bare retina. Stage 2 is a raised ridge. Stage 3 means abnormal new vessels are growing off the ridge into the eye. Stage 4 is a partial retinal detachment, and stage 5 is a complete one.

Plus disease is a separate flag. When the retinal vessels near the optic nerve become noticeably widened and tortuous, it signals aggressive activity and raises the urgency of any stage.

The American Academy of Pediatrics guidance combines these into two practical labels. Type 1 ROP, which generally warrants treatment, includes zone I disease with plus disease at any stage, zone I stage 3 without plus disease, and zone II stage 2 or 3 with plus disease. Type 2 ROP, which is watched closely rather than treated, includes zone I stage 1 or 2 without plus disease and zone II stage 3 without plus disease.

A written report might read: zone II, stage 1, no plus disease, review in two weeks. Translated, that means mild early change in the middle ring, no sign of aggression, and another look shortly. Asking the doctor to translate each line is entirely appropriate.

How often are the follow-up exams, and when does screening stop?

A single exam almost never settles the question. Because ROP evolves over weeks, the interval to the next exam is set by what the doctor saw this time. The American Academy of Pediatrics policy statement lays out typical intervals, summarized below.

What the exam shows	Typical interval to next exam
Immature vessels ending in zone I, or stage 1 or 2 disease in zone I	One week or less
Immature vessels in posterior zone II, stage 2 in zone II, or regressing zone I disease	One to two weeks
Stage 1 in zone II, or regressing zone II disease	Two weeks
Immature vessels in zone II with no ROP, or stage 1 or 2 in zone III	Two to three weeks

These are guideline ranges, not guarantees, and the examining ophthalmologist may shorten an interval if the picture looks unsettled. Babies with the most immature retinas, or with any zone I findings, are seen most frequently because that is where disease can accelerate fastest.

Screening ends when one of several conditions is met, again following the American Academy of Pediatrics guidance: the retinal vessels have reached zone III without prior zone I or II disease; the retina is fully vascularized; the baby reaches 50 weeks postmenstrual age with no prethreshold disease ever recorded; or ROP that was present has clearly regressed with no abnormal tissue left that could reactivate. For many babies this happens before they go home; for others, one or more exams take place in an outpatient clinic after discharge.

That last point deserves emphasis. A baby discharged from the neonatal unit with screening still active has an appointment that cannot safely be skipped or postponed. The window in which treatment helps does not pause because the baby is home.

What the following days and weeks usually look like

In the hours after an exam, most babies are simply tired. The pupil-widening drops keep the pupils large for several hours, so the baby may squint or turn away from bright light; dimming the cot area helps. A small number of infants have brief episodes of slowed heart rate or pauses in breathing during or shortly after the procedure, which is why monitoring continues afterward. Feeding usually resumes according to the unit’s routine once the baby has settled.

Redness around the eyes or slight puffiness of the eyelids from the speculum is common and typically fades within a day. Cleveland Clinic notes that the exam itself does not damage the eye, though it is uncomfortable while it lasts.

Between exams, life in the unit carries on. Nothing a parent does or does not do in that period causes or prevents ROP; it is driven by the retina’s own developmental timetable. What parents can usefully do is keep track of the next exam date and make sure it travels with the baby if there is a transfer to another unit or a move toward discharge.

When screening finishes, the eye team’s involvement does not end entirely. Children born very preterm have higher rates of nearsightedness, misaligned eyes (strabismus) and reduced vision in one eye (amblyopia) than children born at term, whether or not they had ROP. The National Eye Institute and the American Academy of Pediatrics both advise ongoing eye checks through early childhood, with the interval set by the ophthalmologist. A typical pattern is a review in the first year and then periodic checks before school age, adjusted to the individual child.

For the family, then, the timeline has two phases: an intense few weeks of frequent exams, followed by a much longer, lower-key period of routine eye care.

What happens if the exam finds ROP that needs treatment?

Most screened babies never reach this point. For those who do, the finding is usually type 1 ROP, and the American Academy of Pediatrics guidance recommends that treatment take place within 72 hours of that diagnosis where possible, because disease at this stage can progress quickly.

Two broad approaches are in use, and the choice between them rests with the treating ophthalmologist in discussion with the family.

Laser photocoagulation treats the bare, oxygen-starved outer retina with hundreds of tiny laser burns. The rationale, explained by the National Eye Institute, is that this peripheral tissue is the source of the chemical signals driving abnormal vessel growth; reducing it lowers the drive. Laser is performed with the baby sedated or under anesthesia, and it permanently sacrifices some peripheral vision in exchange for protecting central sight.

The second approach uses medicines that block vascular endothelial growth factor, the main protein signaling for new vessels, injected into the eye. This class of treatment can be done more quickly at the bedside and spares peripheral retina, but the disease can reactivate weeks or months later, so follow-up exams continue for longer than after laser. Questions about which medicine, how it is given and how the baby is monitored belong with the prescribing team; guidelines describe mechanisms and follow-up principles rather than fixed rules.

If ROP has already progressed to stage 4 or 5 with retinal detachment, surgery to relieve the pulling on the retina may be offered. Outcomes at that stage are more limited, which is the fundamental reason screening aims to catch disease earlier.

Whatever the treatment, the goal is the same: to halt abnormal vessel growth before it scars and pulls the retina, giving the eye the best chance to develop normally.

What are the latest guidelines for ROP screening, and how are they evolving?

The framework most neonatal units in the United States follow is the American Academy of Pediatrics policy statement, developed jointly with ophthalmology organizations and available through PubMed. Its core elements have been stable for years: screen by birth weight and gestational age, add clinically unstable larger babies at the neonatologist’s discretion, begin at 31 weeks postmenstrual age or four weeks of life, and set follow-up intervals by findings.

What has shifted is the search for more precise ways to decide who truly needs an exam. The weight-and-gestation thresholds cast a deliberately wide net, so most examined babies never develop treatable disease. Researchers have developed risk models that add early postnatal weight gain to the calculation, on the principle that a baby who is growing well is producing the growth factors the retina needs. Several such models have been validated in large cohorts and shown to reduce the number of exams while capturing the babies who need treatment. The American Academy of Pediatrics statement acknowledges these tools as promising but has not adopted any as a replacement for the standard criteria, and units that use them typically do so alongside, rather than instead of, the conventional rules.

Digital imaging and remote reading have grown, particularly for units without an ophthalmologist on site. The guidance accepts imaging within a program that has clear protocols for who reads the images, how quickly, and how abnormal findings trigger a direct exam.

Classification has also been refined. An updated international classification of ROP describes a more aggressive pattern, previously called aggressive posterior ROP, that can progress without passing through the classic stages, and it clarifies how to document regression and reactivation after treatment.

For parents, the practical takeaway is that the schedule your unit follows is anchored in a long-standing consensus, and any newer risk tools in use are meant to refine, not loosen, that safety net.

What people often get wrong about ROP screening

Misunderstandings about ROP are common, partly because the disease is invisible and partly because older information lingers online. A few corrections.

The exam means something is already wrong. It does not. Screening is triggered by birth details, not by any sign of disease. A baby who meets the criteria is examined even when the retina turns out to be entirely normal, which is the most common result.

Oxygen causes ROP, so the baby should have had less. Excess oxygen in the first days was a major driver in past decades, and MedlinePlus still lists high oxygen exposure as a risk factor. Modern units target oxygen ranges carefully, but too little oxygen carries its own serious risks, and ROP occurs even with meticulous management because immaturity itself is the root cause.

If the first exam is clear, the baby is done. A clear early exam simply means disease has not appeared yet. The retina continues developing for weeks, and follow-up continues until the vessels have finished growing or the ophthalmologist formally discharges the baby.

Mild ROP always leads to blindness. The National Eye Institute is explicit that most babies with ROP have a mild form that resolves on its own. Severe, vision-threatening disease is the exception, and screening exists precisely to find that exception in time.

The exam is dangerous or damages the eye. It is uncomfortable and stressful for a short period, and monitoring is needed, but the exam itself does not injure the retina.

Parents could spot ROP if they looked closely. They cannot. Early and moderate ROP produces no external sign, no cloudiness and no change in behavior. Only a dilated exam or retinal photography can detect it, which is the whole reason a structured program exists rather than relying on observation.

Questions to ask your care team

Neonatal units are busy, and eye exams often happen when parents are not at the bedside. Having a short list ready helps you get the information you need without feeling you are interrupting. These questions are a starting point; add your own.

• Does my baby meet the criteria for ROP screening, and if so, which one: birth weight, gestational age or clinical course?
• What is the expected date of the first exam, and can it be written on the cot card or in the notes so I can plan to be present?
• Who performs the exams here, and will the same doctor usually see my baby each time?
• Does the unit use a direct exam, retinal photography, or both?
• What comfort measures are used during the exam, and can I hold my baby’s hand or help swaddle?
• After each exam, can someone explain the zone, stage and plus-disease findings in plain words and tell me the date of the next exam?
• If my baby is transferred or discharged before screening ends, how is the next appointment arranged, and who do I call if I have not heard?
• If treatment were ever needed, what options does the team usually consider, and how quickly would it happen?
• Once screening is complete, when should my child have their next eye check, and with whom?
• Are there any signs in the months after discharge that should prompt me to call the eye clinic rather than wait for the scheduled visit?

Write the answers down. Screening spans weeks, sometimes across two care settings, and a simple page in a notebook or phone with dates and findings is the most reliable way to keep the thread intact.

When to call your doctor

During the screening period, the most important thing you can do is make sure every scheduled exam happens. Missing or delaying an appointment while the retina is still developing is the single most avoidable risk, so if an appointment is cancelled, moved or simply not communicated, call the neonatal unit or eye clinic the same day rather than waiting for the next contact.

After discharge, a few signs warrant a prompt call to your pediatrician or the eye clinic, even if a check is already booked:

• A white, gray or cloudy appearance in the pupil, or a pupil that reflects white instead of red in photographs.
• An eye that consistently turns inward or outward, or eyes that do not move together, beyond the first few months of life.
• A baby who does not seem to fix on faces or follow a slowly moving object by the age the pediatrician would expect for their corrected age.
• Persistent redness, swelling, discharge or apparent pain in an eye, particularly after any eye treatment.
• Any sudden change in how the eyes look or behave that worries you.

Seek urgent care the same day if a baby who has had an eye injection or laser treatment develops a swollen, red or weeping eye with fever or unusual irritability, since infection inside the eye, though rare, needs immediate assessment.

None of these signs confirms ROP or any other diagnosis; several have ordinary explanations. Their purpose is to prompt an examination by someone equipped to look properly. As with every step of this process, the interpretation and the decisions rest with the treating team, and no list can replace a conversation with the doctors who know your child.

Frequently asked questions

What are the screening criteria for retinopathy of prematurity?

The American Academy of Pediatrics recommends screening infants with a birth weight of 1,500 grams or less or a gestational age of 30 weeks or less. Babies weighing between 1,500 and 2,000 grams or born after 30 weeks may also be screened if their clinical course has been unstable, such as prolonged breathing support, at the discretion of the neonatologist. Other countries use similar thresholds with small local differences.

Who qualifies for the ROP exam if the baby is bigger than 1,500 grams?

Larger or more mature babies qualify only when the treating neonatologist judges them to be at increased risk because of an unstable course. Factors that may prompt this include prolonged oxygen or ventilator support, serious infection, poor weight gain or repeated transfusions. A healthy 33-week baby who breathed independently from birth would not normally be examined, because the retina is already largely developed.

When is the recommended screening time for retinopathy of prematurity?

The first exam is recommended at 31 weeks postmenstrual age or four weeks after birth, whichever is later. A baby born at 24 weeks is first examined around seven weeks of life, while a baby born at 29 or 30 weeks is examined at about four weeks of life. Follow-up exams then occur every one to three weeks depending on findings, until the retina is fully developed.

What are the latest guidelines for ROP screening?

The current American Academy of Pediatrics policy statement remains the reference standard in the United States, setting criteria by birth weight and gestational age and defining follow-up intervals by zone, stage and plus disease. Newer developments include validated weight-gain-based risk models that may reduce unnecessary exams, wider use of digital retinal imaging with remote reading, and an updated international classification that describes aggressive ROP and documents regression and reactivation more precisely.

Does the ROP exam hurt a premature baby?

The exam is uncomfortable rather than harmful. The eyelid speculum and bright light cause most babies to cry, and heart rate or oxygen readings may dip briefly. Units use numbing drops, swaddling, a pacifier, a small amount of sugar solution and parental touch to reduce distress. The procedure lasts a few minutes per eye, and the eye itself is not injured, though mild eyelid puffiness for a day is common.

How many ROP exams will my baby need?

There is no fixed number. A baby whose retina develops normally may need only two or three exams spaced two to three weeks apart. A baby with early ROP or very immature vessels may be examined weekly for several weeks. Screening stops when the vessels reach the outer retina, the retina is fully vascularized, the baby reaches 50 weeks postmenstrual age without significant disease, or ROP has clearly regressed.

What are the ROP stages and zones, and which ones need treatment?

Zones describe location, with zone I nearest the optic nerve and zone III at the outer edge. Stages 1 through 5 describe severity, from a faint demarcation line to complete retinal detachment. Plus disease indicates dilated, twisted vessels. Treatment is generally advised for type 1 ROP: any zone I disease with plus disease, zone I stage 3, or zone II stage 2 or 3 with plus disease.

Can ROP go away on its own?

Yes, in most cases. The National Eye Institute notes that most babies who develop ROP have a mild form that regresses without treatment as the retina completes its development. Screening continues until the ophthalmologist documents that regression, because a minority of babies progress to more severe disease that requires laser or an injected medicine to prevent scarring and retinal detachment.

What happens if we miss an ROP screening appointment after discharge?

Contact the eye clinic or neonatal unit the same day to rebook. The window in which treatment can protect vision is measured in weeks, and severe disease can develop between exams, so a missed appointment while screening is still active is the most important avoidable risk. Units typically treat these as urgent and can usually arrange a prompt slot.

Does a normal ROP screen mean my child will never have eye problems?

No. Children born very preterm have higher rates of nearsightedness, strabismus and amblyopia than children born at term, regardless of ROP. Guidance from the National Eye Institute and the American Academy of Pediatrics recommends continued eye checks through early childhood, with intervals set by the ophthalmologist. A clear screen is reassuring about ROP specifically, not a lifetime guarantee of normal vision.

References

• Retinopathy of Prematurity – National Eye Institute, NIH
• Retinopathy of prematurity – MedlinePlus Medical Encyclopedia

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.